| Product Information |
|
| Registration Number |
BRP-053
|
| Generic Name |
Reteplase (Recombinant Tissue Plasminogen Activator)
|
| Brand Name |
Mirel
|
| Dosage Strength |
10 Units
|
| Dosage Form |
Lyophilized Powder For Injection (Iv)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
USP Type I Glass Vial x 20mL (Box of 1's)
|
| Pharmacologic Category |
Antithrombotic
|
| Manufacturer |
Reliance Life Sciences Pvt. Ltd. (Plant II)
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Ambica International Corporation
|
| Distributor |
Ambica International Corporation
|
| Application Type |
Automatic Renewal
|
| Issuance Date |
03 October 2022
|
| Expiry Date |
18 July 2028
|